Brivaracetam Tablet, Film Coated
Product Images NDC 50228-560

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Brivaracetam (NDC 50228-560). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Brivaracetam 01)

Figure 1 (Brivaracetam 01)
A bar chart showing the proportion of patients (%) by reduction in seizure frequency from baseline (%) comparing placebo and brivaracetam dosages (50 mg/day, 100 mg/day, 200 mg/day). The X-axis displays seizure frequency reduction categories (Worse, 0 to <25, 25 to <50, 50 to <75, 75 to 100), and the Y-axis shows patient proportion percentage.*
FDA Label Image

Principal Display Panel (10 mg 30 tablets)

Principal Display Panel (10 mg 30 tablets)
Brivaracetam Tablets 10 mg film-coated oral tablets label from ScieGen Pharmaceuticals, Inc. The label indicates each tablet contains 10 mg brivaracetam. It specifies storage instructions, usual dosage reference, and packaging in 30 tablets with Rx only. The label includes a barcode and advises dispensing the accompanying medication guide.*
FDA Label Image

Principal Display Panel (10 mg 60 tablets)

Principal Display Panel (10 mg 60 tablets)
The packaging label for brivaracetam tablets 10 mg, a film-coated oral tablet by ScieGen Pharmaceuticals, Inc. The label includes dosage strength, quantity of 60 tablets, NDC 50228-556-60, barcode, storage instructions, and a warning to keep medication out of reach of children. It also states 'NO VARNISH' on the side panel.*
FDA Label Image

Principal Display Panel (10 mg 1000 tablets)

Principal Display Panel (10 mg 1000 tablets)
Label for Brivaracetam tablets 10 mg by ScieGen Pharmaceuticals, Inc. The film-coated oral tablets package contains 1,000 tablets. The label includes storage instructions, dosage reference to accompanying prescribing information, and child-resistant container warning, along with the NDC 50228-556-10 and barcode.*
FDA Label Image

Principal Display Panel (25 mg 30 tablets)

Principal Display Panel (25 mg 30 tablets)
Brivaracetam Tablets 25 mg film-coated oral tablets label. The package contains 30 tablets and is labeled by ScieGen Pharmaceuticals, Inc. The label includes storage instructions, dosage caution, and a note to dispense the accompanying medication guide. The product NDC is 50228-557-30.*
FDA Label Image

Principal Display Panel (25 mg 60 tablets)

Principal Display Panel (25 mg 60 tablets)
Label for Brivaracetam 25 mg film-coated tablets by ScieGen Pharmaceuticals, Inc. The label indicates each tablet contains 25 mg of brivaracetam. It includes storage instructions, dosage guidance to refer to prescribing information, and child-resistant packaging requirements. The package contains 60 tablets and is for prescription use only. The label also shows the NDC number 50228-557-60 and a barcode.*
FDA Label Image

Principal Display Panel (25 mg 1000 tablets)

Principal Display Panel (25 mg 1000 tablets)
Brivaracetam 25 mg film-coated tablets packaging label by ScieGen Pharmaceuticals, Inc. The label shows the product name and strength prominently in blue and white with a red background for the strength. It includes dosage, storage instructions, quantity (1,000 tablets), a barcode, and manufacturer information. The label is marked Rx only and includes a note cautioning to keep medication out of reach of children and to dispense with a medication guide.*
FDA Label Image

Principal Display Panel (50 mg 30 tablets)

Principal Display Panel (50 mg 30 tablets)
Brivaracetam Tablets 50 mg film-coated oral tablets label from ScieGen Pharmaceuticals, Inc. The label includes dosage strength, quantity of 30 tablets, storage instructions, and a barcode. It states the product is prescription only (Rx Only) and advises dispensing the accompanying medication guide with each patient.*
FDA Label Image

Principal Display Panel (50 mg 60 tablets)

Principal Display Panel (50 mg 60 tablets)
Brivaracetam 50 mg film-coated tablets label by ScieGen Pharmaceuticals, Inc. The label states the strength as 50 mg per tablet, with a package containing 60 tablets. It includes storage instructions and a note to dispense the medication guide to each patient. The label features a barcode, NDC number 50228-558-60, and is marked Rx only.*
FDA Label Image

Principal Display Panel (50 mg 1000 tablets)

Principal Display Panel (50 mg 1000 tablets)
Label for Brivaracetam Tablets 50 mg, film-coated oral tablets. The label shows the active ingredient as brivaracetam with a strength of 50 mg per tablet. The package contains 1,000 tablets and is labeled for prescription use only (Rx Only). The manufacturer is ScieGen Pharmaceuticals, Inc. Additional information includes storage instructions and a barcode.*
FDA Label Image

Principal Display Panel (75 mg 30 tablets)

Principal Display Panel (75 mg 30 tablets)
Label for Brivaracetam Tablets 75 mg by ScieGen Pharmaceuticals, Inc. The film-coated oral tablets come in a package of 30. The label includes storage instructions, dispensing warnings, and advises to see accompanying prescribing information. It features the product name, strength, NDC 50228-559-30, barcode, and manufacturer details.*
FDA Label Image

Principal Display Panel (75 mg 60 tablets)

Principal Display Panel (75 mg 60 tablets)
Brivaracetam 75 mg film-coated tablets label from ScieGen Pharmaceuticals, Inc. The label states 60 tablets per container, prescription only, and includes storage instructions, dosage advisory, and a barcode. The label also features the ScieGen Pharmaceuticals logo and specifies no varnish on the tablet coating.*
FDA Label Image

Principal Display Panel (75 mg 1000 tablets)

Principal Display Panel (75 mg 1000 tablets)
Brivaracetam Tablets 75 mg film-coated oral tablets label. The package contains 1,000 tablets and is labeled for prescription use only. It is manufactured by ScieGen Pharmaceuticals, Inc. Storage instructions and dosage cautions are printed on the left side, along with the NDC 50228-559-10 and a barcode on the right.*
FDA Label Image

Principal Display Panel (100 mg 30 tablets)

Principal Display Panel (100 mg 30 tablets)
Brivaracetam 100 mg film-coated tablets label including dosage form, strength, and manufacturer ScieGen Pharmaceuticals, Inc. The label notes storage instructions, quantity of 30 tablets, and prescription-only status with barcode and NDC 50228-560-30.*
FDA Label Image

Principal Display Panel (100 mg 60 tablets)

Principal Display Panel (100 mg 60 tablets)
Label for brivaracetam 100 mg film-coated tablets by ScieGen Pharmaceuticals, Inc. The label states 100 mg strength with 60 tablets per container, for oral use. It includes storage instructions, dosage guidance, and a barcode. The label also notes no varnish and has manufacturer details including location in Hauppauge, NY.*
FDA Label Image

Principal Display Panel (100 mg 1000 tablets)

Principal Display Panel (100 mg 1000 tablets)
Label for Brivaracetam Tablets 100 mg, film-coated oral tablets by ScieGen Pharmaceuticals, Inc. The label includes dosage strength, storage instructions, dispensing information, and a barcode. The package contains 1,000 tablets and is marked Rx Only. The label also states 'NO VARNISH' on the right side.*
FDA Label Image

Chemical Structure (Chemical Structure)

Chemical Structure (Chemical Structure)
Chemical structure diagram of brivaracetam, showing its molecular framework including a pyrrolidinone ring and an amide group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.